Controlled release and mucosal delivery systems offer alternative ways to deliver drugs with improved consistency, faster onset, or avoidance of first‑pass metabolism. This article explains oral and parenteral controlled release, as well as sublingual and buccal delivery, in simple terms—focusing on mechanisms, advantages, and limitations.
1. Oral Controlled Release Systems
What they are
- Formulations designed to release drug over extended time after oral administration
How they work
- Release controlled by:
- Diffusion (matrix systems)
- Erosion (hydrophilic polymers)
- Osmotic pressure (osmotic pumps)
Key goals
- Maintain therapeutic plasma levels
- Reduce dosing frequency
- Improve patient compliance
Challenges
- Variable GI transit
- First-pass metabolism
- Food effects
2. Parenteral Controlled Release Systems
What they are
- Injectable systems (IM, SC, very rare IV) designed for sustained or depot release
How they work
- Drug release controlled by:
- Polymer degradation (e.g., PLGA)
- Diffusion from depot
- In situ gel formation
Examples
- Microspheres
- Implants
- In situ forming gels
- Liposomal formulations
Advantages
- Bypass GI tract and first-pass metabolism
- Long duration (days to months)
Limitations
- Invasive
- Difficult to reverse once administered
3. Sublingual Drug Delivery
What it is
- Drug placed under the tongue
How it works
- Absorption through highly vascularized mucosa
- Direct entry into systemic circulation
Advantages
- Rapid onset
- Avoids first-pass metabolism
- Useful for unstable drugs
Limitations
- Small dose only
- Taste issues
- Saliva washout
4. Intraoral (Buccal) Drug Delivery
What it is
- Drug administered to the cheek mucosa
How it works
- Diffusion across buccal epithelium
- Often uses mucoadhesive systems
Advantages
- Sustained release possible
- Better patient control than sublingual
Limitations
- Limited surface area
- Irritation potential
Delivery Systems in Simple Terms — Series Index
This article is Part 3 of a three‑part series “Delivery Systems in Simple Terms.”
- Part 1 — Nanoemulsions, Liposomes, and Nanoparticles
- Part 2 — Lipid‑Based Nanocarriers (SLNs and NLCs)
- Part 3 — Controlled Release, Sublingual, and Buccal Delivery (current article)
For a simple overview of absorption barriers and bioavailability fundamentals, see our previous article: Bioavailability Explained
For a broader overview of the field, see the Wikipedia article on Drug delivery.
